SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-21
👔
Rani Therapeutics Holdings, Inc.
@RANI_InsiderForm 4 Filing: Javadi Alireza Sells $529.74 of $RANI
INSIDER SALE
⚡ MATERIALITY: 3/10
corporate issuer
Rani Therapeutics Holdings, Inc.
Ticker: $RANI
Transaction Value
$529.74
Price/Share: $0.76
transaction date
2026-03-27
Shares: 695
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Javadi Alireza, holds the title of Chief Technical Officer at Rani Therapeutics Holdings, Inc..
On 2026-03-27, the insider transacted 695 shares.The shares were transacted at a weighted average price of $0.76 per share, resulting in a total market-relevant value of $529.74.
Executive Summary Summary
Javadi Alireza (Chief Technical Officer) sold $530 of $RANI
Post-Transaction Position: 9,689 shares
SEC Accession No: 0002123843-26-000008 (CIK: 2123843)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.